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doi:10.1016/j.ejvs.2010.05.011Abstract Introduction: Deep vein thrombosis (DVT) after varicose vein surgery is well recog-
nised. Less well documented is endovenous heat-induced thrombosis (EHIT), thrombus exten-
sion into a deep vein after superficial venous thermoablation. We examined the rates of DVT in
our unit after radiofrequency (RFA) and endovenous laser ablation (EVLA) with specific atten-
tion to thrombus type.
Method: Retrospective analysis of all cases of RFA under general anaesthesia and EVLA under
local anaesthesia was performed. Cases of DVTwere identified from the unit database and ana-
lysed for procedural details.
Results: In total, 2470 cases of RFA and 350 of EVLA were performed. Post-RFA, DVT was iden-
tified in 17 limbs (0.7%); 4 were EHIT (0.2%). Concomitant small saphenous vein (SSV) ligation
and stripping was a risk factor for calf-DVT (OR 3.4, 95%CI 1.2e9.7, PZ 0.036), possibly due to
an older patient group with more severe disease. Post-EVLA, 4 DVTs were identified (1%), of
which 3 were EHIT (0.9%).
Conclusion: The DVT rate including EHIT was similar in patients treated with RFA and EVLA and
was low. Routine post-operative duplex ultrasound scanning is recommended until the signif-
icance of EHIT is better understood, in accordance with consensus guidelines. DVT rates for
both techniques compare favourably with those published for saphenous vein stripping.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Meeting of the Association of Surgeons of Great Britain and Ireland, Manchester 2007, Session W2c1
2007 Oral presentations. Br J Surg 2007;94(S2): 1e78).
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522 P. Marsh et al.Introduction was cannulated percutaneously just below the knee. A 0.025-Deep vein thrombosis (DVT) after varicose vein surgery is
well recognised.1,2 With the growing popularity of endo-
venous thermo-ablative techniques, there have been
numerous reports of the complication Endovenous Heat-
Induced Thrombosis (HIT).3,4 EHIT is thrombus extending
from the superficial venous system into the deep venous
system at, or proximal to, a site of recent thermoablation,
most commonly thrombus extending from the great
saphenous vein (GSV) into the common femoral vein (CFV,
Fig. 1).5 The aim of this study was to compare rates of
venous thromboembolism (VTE) after endovenous radio-
frequency (RFA) and laser ablation (EVLA) with specific
attention to thrombus type and risk factors.
Method
Aretrospectiveanalysisofall casesofRFAandEVLAperformed
in the unit from February 1999 to March 2007 was conducted.
Cases of DVTwere identified from the unit database in which
patient demographics, severity of venous insufficiency
according to CEAP clinical classification,6 procedural details
and all complications are prospectively recorded. For those
patients in whom post-operative DVT was identified, case
notes were examined for previous venous thromboembolism
(VTE), VTE risk factors, history of varicose vein surgery and
procedural details. Redo procedureswere classified as surgery
to the same vein if any previous intervention had been per-
formed (e.g. ligation or stripping procedure).
Radiofrequency ablation
Our technique for RFA has previously been described.7 Briefly,
all cases in this study were performed under general anaes-
thesia (GA) using the Closure system (VNUS medical tech-
nologies, San Jose, California). Tumescent local anaesthesia
was not used. High resolution scanners (Acuson Cypress,
Siemens, Issaquah, USA) handled by experienced vascular
technologists were used for all procedures. A linear 7 MHz
probe (Acuson Cypress) was inserted in a sterile cover with
acoustic coupling gel and using ultrasound guidance the GSVFigure 1 Appearance of Endovenous Heat-induced thrombosis
(EHIT) extending from the great saphenous vein (GSV) into the
common femoral vein (CFV) on duplex ultrasound scan.inch guide-wire was then inserted proximally to the CFV using
the Seldinger technique. An RFA catheter, 6F or 8F according
to the diameter of the GSV, connected to a pressurised hep-
arinised saline infusion (5000 U in 500 ml of saline solution,
150 mmHg) was introduced as far as the saphenofemoral
junction (SFJ). The leg was then bound with an Esmarch
bandage to ensure good contact between the vein wall and
catheter electrodes by venous exsanguination. After con-
firming the proximal limit of the catheter to be within 2 cm of
the SFJ, radiofrequency energy deliverywas commencedwith
a temperature of 85 C. An initial “ring burn”was delivered for
15 s, and the catheter was then withdrawn a distance of 1 cm
in the firstminute, 2 cm in the secondminute, and 2.5e3 cm/
min thereafter, depending on the diameter of the vein. Post-
procedure, the vein was checked immediately with duplex
ultrasound (DUS) for closure. Any incompetent tributaries of
the GSV were treated concomitantly, as were incompetent
perforator veins (IPV), either with DUS-guided perforator
ligation or TransLuminal Occlusion of Perforator (TRLOP) with
RFA.8 Adjunctive phlebectomies were also performed to
remove superficial varicosities which had been marked pre-
operatively on the skin. Incompetent small saphenous veins
(SSV) were treated with concomitant DUS-guided sapheno-
popliteal ligation and strip as previously described.9 After the
procedure a creˆpe bandage was applied firmly to the leg and
thigh over Velband (Johnson & Johnson Medical, Ascot,
Berkshire). This was replaced the next day with a graduated
compression stocking.Endovenous laser ablation
EVLA was introduced as a treatment option to patients in
the unit in May 2005, and all cases performed to March 2007
were included. All cases of EVLA were performed under
tumescent local anaesthesia as walk-in, walk-out proce-
dures. The GSV was cannulated percutaneously just below
the knee under ultrasound guidance using the Seldinger
technique. The laser sheath was advanced to the SFJ and
the guide-wire removed. Tumescent anaesthesia was infil-
trated in the perivenous space under ultrasound guidance
(Acuson Cypress) using an AutoFill syringe (Vascular
Solutions Inc., Minneapolis, USA). 0.5 l of tumescent local
anaesthesia was prepared using 500 ml 0.9% saline, 20 ml of
2% xylocaine and adrenaline and 5 ml of 8.4% sodium
bicarbonate according to Klein’s formula.10 The laser fibre
was inserted to a position within 2 cm of the SFJ with
ultrasound guidance and connected to an 810 nm diode
laser (Vari-Lase, Vascular Solutions Inc., Minneapolis,
USA). Laser energy was then administered at 14 W power
using a continuous setting, aiming for a linear energy
delivery target of 70 J/cm. Refluxing tributaries were
treated with EVLA concomitantly. Treatment of superficial
varicosities and IPV was performed at a later date.Pre-operative evaluation and post-operative
follow-up
All patients were diagnosed pre-operatively with superficial
venous insufficiency according to DUS (SONOLINE Antares,
Table 1 Patient characteristics.
RFA
nZ 2470
EVLA
nZ 350
Median age/y 53 (SDZ 13) 57 (SDZ 14)
F/M 2.8/1 2.8/1
CEAP clinical score
(median, range)
2 (1e6) 2 (1e6)
% limbs in
CEAP Class 0 1 2
1 1 7
2 70 61
3 6 3
4 18 21
5 2 2
6 1 3
RFA, radiofrequency ablation, EVLA, endovenous laser ablation,
SD, standard deviation.
DVT and EHIT after Endovenous Thermoablation 523Siemens, Issaquah, USA) using a standard protocol and
treatment was guided by DUS-directed vein mapping. Vein
incompetence was assessed with reflux in response to
manual calf compression or Valsalva manoeuvre with the
patient standing and reflux was defined as evidence of
reverse flow >500 ms in a vein segment.11 Any patients
undergoing endovenous thermoablation procedures
routinely received one dose of low molecular weight (LMW)
heparin prophylaxis (4000 i.u. enoxaparin sodium, Sanofi-
aventis, Guildford, UK), unless warfarinised for co-morbid
conditions (immediately post-operatively for EVLA, intra-
operatively for RFA). All patients were given 20e30 mmHg
graduated compression stockings (Venosan, Saltzman,
Switzerland) to wear 24 h a day for at least 3 days. Routine
mobilisation was encouraged for the post-operative period.
A duplex ultrasound examination was performed within the
first two post-operative weeks, to assess the treated vein
segment and exclude DVT, with special attention paid to the
SFJ and calf muscle veins. EHIT was classified as previously
described. The presence of thrombus in gastrocnemius,
posterior tibial or popliteal veins was classified as calf-DVT.Statistical analysis
Statistical analysis was performed using Interstat 3 and Prism
software (GraphPad Software, Inc., San Diego, California,
USA). Intergroup comparisons were made with the Student t
orManneWhitney u test as appropriate for normally and non-
normally distributed data, respectively (TT). Univariate
analysis was performed to estimate the effect of selected
risk factors using the chi-squared test for contingency tables.
A P value <0.05 was considered statistically significant.
Results
Patient characteristics
RFAwasperformedon2470 limbsandEVLAon350 limbsduring
the period examined. Patient demographics are summarised
(Table 1). Basic patient characteristics were similar with the
exception of the higher median age in the EVLA group.
Post-operative DVT and EHIT
Post-RFA, DVT was identified in 17 limbs (0.7%). Of these, 4
were EHITand 14were calf-DVT. In onepatient, both types of
thromboses were present, along with pulmonary embolism
(PE). Thiswas theonly caseof PE (confirmedonCTpulmonary
angiography) in the series (0.04%). The patient presented at
routine follow-up 8 days post-RFA complaining of foot drop
since the procedure and chest pain for 36-h. Nerve conduc-
tion studies demonstrated no abnormality and the patient
made a full recovery. Post-EVLA, 4 DVTswere identified (1%):
of these, 3 were EHIT and one a calf-DVT, all post-GSV abla-
tion. The calf-DVT presented after the patient underwent
subsequent treatment of an IPV. Length of GSV treated and
energy applied in each case are described (Table 3). Of the
limbs treated with EVLA, 48 cases were small saphenous
veins. There was no DVT or EHIT in this sub-group. The
frequency of EHIT was similar following RFA and EVLA butsince this event occurred in very few patients no reliable
statistical analysis is possible (Table 2).Risk factors for DVT and EHIT
There was no significant difference between the age of the
patientswho had a calf-DVTor EHIT post-RFA or EVLA and the
population undergoing RFA as a whole, nor was there
a difference in the proportions of limbs in each clinical score.
Of the patients with calf-DVT post-RFA, 3 had previous DVT
(21%). None of the patients with EHIT post-RFA had a history
of DVT, in contrast with 2 of 3 patients with the condition
post-EVLA, one of whom had evidence of this on pre-opera-
tive DUS. Other possible risk factors were present for 2 of the
calf-DVT post-RFA (no cessation of oral contraceptive pill,
hormone replacement therapy use), though for none of the
EHIT in the series. All patients with calf-DVT or EHIT had
received heparin prophylaxis (Table 4).
Post-RFA, the rate of calf-DVT for bilateral surgery
compared with unilateral surgery was similar (PZ N.S.).
Redo surgery compared with primary surgery did not cause
a higher rate of DVT. Concomitant small saphenous surgery
(SST) with RFA was found to be a risk factor for calf-DVT
when compared with RFA and no small saphenous surgery
(PZ 0.036). No significant difference was seen between
the rate of calf-DVT for concomitant RFA and SST proce-
dures, and small saphenous surgery procedures performed
in the same period alone (PZ N.S.) suggesting concomitant
small saphenous surgery itself to be a possible risk factor
for calf-DVT post-RFA. Further analysis demonstrated that
patients in the RFA and concomitant SST group were
significantly older, with limbs in a higher CEAP clinical class
than patients who had RFA without SST (PZ 0.028 and
P  0.0001). When comparing those groups having any small
saphenous surgery (RFAþ SST or SST alone), patients were
similar for age and CEAP clinical class.
The significance of treatment of IPVs with the TRLOP
method was also examined. An increased OR of calf-DVTwas
seen after RFA and TRLOP compared with RFA and no TRLOP
Table 2 DVT and HIT rates after RFA and EVLA.
RFA EVLA P (c2) CI
Total no. of limbs 2470 350
Any DVT (%) 17 (0.7) 4 (1) 0.55 (0.35) 0.20e1.80
Calf-DVT (%) 14 (0.57) 1 (0.3) 0.77 (0.08) 0.26e15
EHIT (%) 4 (0.16) 3 (0.9) 0.06 (3.5) 0.04e0.84
PE (%) 1 (0.04) 0 e
CI, confidence interval, DVT, deep vein thrombosis, EHIT, endovenous heat-induced thrombosis, PE, pulmonary embolism, RFA, radi-
ofrequency ablation, EVLA, endovenous laser ablation, c2, chi-square.
524 P. Marsh et al.(OR 5.8, PZ 0.02). No significant difference in the rate of
calf-DVT after RFA and TRLOP was seen compared with
TRLOP alone performed without RFA of a truncal vein in the
same period (OR 3.4, PZ 0.28). It was noted that 6 of the
calf-DVT seen after TRLOP were also associated with small
saphenous surgery, and so these were analysed separately.
There was no increased risk of calf-DVT after RFA and TRLOP
and no small saphenous surgery compared with RFA alone
(also excluding those with small saphenous surgery).
However, theodds ratio of calf-DVTafter RFAandTRLOPwith
small saphenous surgery was significantly elevated when
compared with RFA and TRLOP and no small saphenous
surgery (OR 3.5, PZ 0.03). Of the calf-DVT seen with
concomitant small saphenous surgery, all patients also had
concomitant treatment of an IPV in the same limb (nZ 7).
Although 6 of these had the TRLOP procedure, 1 patient had
duplex-guided perforator ligation. The OR of calf-DVT with
RFA and small saphenous surgery and treatment of an IPVwas
significantly elevated compared with those who did not have
IPV treatment (OR 14.7, PZ 0.015, Table 5).
Management of DVT/EHIT
The management of patients with EHIT evolved in the series
(Table 6). The first patient with EHIT post-RFA was managed
with open saphenofemoral thrombectomy, SFJ ligation and
anticoagulation with warfarin for 6 weeks. Subsequently,
the patients with isolated EHIT post-RFA were treated
medically with warfarin for a one-month period (3-months
for the patient with PE).
Similarly for patients with EHIT post-EVLA: one patient
was warfarinised for a 1-month period, one patient was
treated with a therapeutic once e daily dose of low molec-
ular weight heparin and one patient was observed without
treatment, without consequence. Regression of thrombus
from the deep vein was established on DUS before cessation
of anticoagulation in all patients. With the exception of the
patient with calf-DVT thought to be related to IPV treatmentTable 3 Length of great saphenous vein treated with endoveno
complicated by HIT or DVT.
Case no. Type of thrombus Length of GSV treat
1 EHIT 9
2 EHIT 22.8
3 EHIT 31
4 DVT 20
GSV, great saphenous vein, DVT, deep vein thrombosis, EHIT, endov
density.post-EVLA (in whom the DVT resolved without treatment
after 5 days), all patientswith isolated calf-DVTpost-RFAand
EVLAwerewarfarinised (mean10weeks, range 3e14weeks).
No caval filters were utilised.
Discussion
We found a low incidence of DVT after EVLA and RFA in this
retrospective analysis with no clear difference between
these treatments and very few EHITs were seen. The mech-
anism of EHIT formation is not fully understood. Superficial
venous thrombus is expected following thermoablation,
whether this is by thrombotic vessel occlusion or local vessel
injury from direct thermal damage or steam bubbles.12,13
Thrombus may form in the deep veins or propagate from
treated superficial veins to the deep veins.
Reported rates of DVT post-endovenous ablation tech-
niques vary widely from 0 to 16% post-RFA and 0 to 7.7%
post-EVLA.4 Rates after conventional surgery vary between
0.4% historically and 5.7% with prospective ultrasound.1,2
The series reported here includes our learning curve for
EVLA but despite this we did not observe a difference in
DVT rates between EVLA and RFA.
Factors which may increase the risk of EHIT include:
patient age, undiagnosed hypercoagulable states and
severity of chronic venous disease.14,15 Factors related to
the procedure include: the use of GA, maintenance of
patency of superficial venous tributaries at the most prox-
imal point of thermoablation, avoidance of catheterising the
CFV to avoid intimal damage and the avoidance of propa-
gation of steam bubbles (or thrombus) by compression or
ligation of the SFJ, though a recent survey has indicated no
difference in DVT rate of ligators and non-ligators.3,16e18 Our
practice was to perform RFA under GA using an Esmarch
bandage to exsanguinate the limb. We did not use tumescent
anaesthesia in this group in order to avoid the “heat sink”
effect, without adversely affecting the DVT rate. Addition-
ally, it has been our practice to perform concomitantus laser ablation and the amount of energy delivered in cases
ed (cm) Total laser energy (J) LEED (J/cm))
582 64.7
1574 69.0
2127 68.6
1446 72.3
enous heat-induced thrombosis, LEED, linear endovenous energy
Table 4 Risk factors for venous thromboembolism and procedural factors for patients with DVT or HIT post-endovenous
thermoablation.
No. of
cases of
DVT
Median Age
(range)
C2 C3 C4 Previous
DVT
Other
RF
Bilateral
surgery
Redo SST TRLOP RFA of
AAGSV
RFA
Calf-DVT 14 47 (39e69) 10 0 4 3 2 2 4 7 12 4
EHIT 4 56 (42e69) 2 1 1 0 0 2 0 0 2 1
EVLA
Calf-DVT 1 e 0 0 1 0 0 e 0 e 0 0
EHIT 3 58 (57e75) 1 0 2 2 0 e 0 e 0 0
DVT, deep vein thrombosis, EHIT, endovenous heat-induced thrombosis, PE, pulmonary embolism, RFA, radiofrequency ablation, EVLA,
endovenous laser ablation, RF, risk factor, SST, small saphenous surgery, TRLOP, transluminal occlusion of perforator, AAGSV, anterior
accessory great saphenous vein.
DVT and EHIT after Endovenous Thermoablation 525phlebectomy in these patients. In the first 127 cases of RFA
performed in this series, we found that 57% of superficial
epigastric veins (SEV) remained patent with no relationship
with neovascularisation at the SFJ or GSV recanalisation,
a finding also seen post-EVLA.7,19 Nevertheless, it has not
been our practice to routinely commence ablation below this
vein in part due to the variability of its site. We commenced
thermoablation within 2 cm of the SFJ, regardless of SEV site
and routinely used a guide-wire, placing the catheter in the
CFV and withdrawing the tip into the saphenofemoral hood.
The small numbers of EHIT seen prevented meaningful
analysis of risk factors but larger numbers of calf-DVTpost-RFATable 5 Risk factors for calf-DVT post-RFA.
Risk factor N (%) DV
Bilateral surgery
Bilateral RFA 1056 2
Unilateral RFA 1414 12
Redo surgery
Redo surgery 597 4
Primary surgery 1873 10
Small saphenous surgery
RFAþ SST 567 7
RFA no SST 1903 7
SST no RFA 285 3
Treatment of IPV
RFAþ TRLOP 1265 12
RFA no TRLOP 1205 2
TRLOP no RFA 32 1
RFAþ TRLOP no SST 984 6
RFA no TRLOP no SST 919 1
RFAþ TRLOPþ SST 289 6
RFAþ SSTþ TRLOP 289 6
RFAþ SST no TRLOP 278 1
RFAþ SSTþ TIPV 290 7
RFAþ SSTþ no TIPV 277 0
DVT, deep vein thrombosis, RFA, radiofrequency ablation, SST, small s
TRLOP, transluminal occlusion of perforator, OR, odds ratio, CI, confi
a Univariate analysis using chi-square test.enabled further analysis of this sub-group.Surprisingly the rate
of calf-DVT was reduced in patients having bilateral surgery
comparedwithunilateral, contrary toexpectationandfindings
of others.20 The significantly increased rate of calf-DVTseen in
patients undergoing concomitant small saphenous surgery and
RFA is possibly attributable to the increased age and clinical
severity score in this group of patients, as their risk of calf-DVT
was found to be similar to those undergoing small saphenous
surgery alone. No DVT was seen following EVLA of small
saphenous veins, although there were few of these cases.
Initially TRLOP appeared to be an isolated risk factor for
calf-DVT but this was linked to concomitant smallT (%) OR (95%CI) Pa
(0.2) 0.22 (0.05e0.99) 0.059
(0.8) e e
(0.7) 1.26 (0.39e4.02) 0.94
(0.5) e e
(1.3) 3.39 (1.18e9.70) 0.036
(0.4) e e
(1.0) 0.82 (0.22e3.32) 0.82
(0.9) 5.76 (1.29e25.8) 0.02
(0.2) e e
(3.2) 3.37 (0.42e26.7) 0.28
(0.6) 5.63 (0.68e46.9) 0.126
(0.1) e e
(2.1) 3.46 (1.11e10.8) 0.03
(2.1) 5.87 (0.70e49.1) 0.123
(0.4) e e
(2.4) 14.7 (0.83e258) 0.015
e e
aphenous surgery, TIPV treatment of incompetent perforator vein
dence interval.
Table 6 Treatment of venous thromboembolism post-RFA.
Type of
thermoablation
DVT
Number
Type of
VTE
Deep vein
containing
thrombus
Treatment Duration of
treatment
RFA 1 HIT CFV Thrombectomy, Warfarin 6 weeks
2 HIT CFV Warfarin 4 weeks
3 Calf DVT Gastroc. Warfarin 7 weeks
4 Calf DVT Gastroc. Observed e
5 Calf DVT Gastroc. Warfarin 12 weeks
6 Calf DVT PV Warfarin 12 weeks
7 Calf DVT Gastroc. Warfarin 12 weeks
8 Calf DVT Gastroc. Warfarin 4 weeks
9 Calf DVT PV Warfarin 14 weeks
10 Calf DVT Gastroc. Warfarin 12 weeks
11 Calf DVT, HIT, PE Gastroc. Warfarin 12 weeks
12 Calf DVT Gastroc. Warfarin 3 weeks
13 Calf DVT Gastroc. Warfarin 5 weeks
14 Calf DVT Gastroc. Warfarin 12 weeks
15 Calf DVT Gastroc. Warfarin 14 weeks
16 HIT CFV LMW heparin 5 days
17 Calf DVT Gastroc. þ PV Warfarin 12 weeks
EVLA 1 HIT CFV Warfarin 4 weeks
2 HIT CFV Observed e
3 HIT CFV LMW heparin 1 week
4 Calf DVT PTV Observed e
Gastroc., gastrocnemius vein, PV, popliteal vein, CFV, common femoral vein, PTV, posterior tibial vein.
Table 7 Classification system for endovenous heat-
induced thrombosis described by Kabnick et al.
Class Thrombus extension (from superficial
vein)
1 Close proximity to superficial-deep
venous junction
2 Extending beyond junction with
cross-sectional diameter of <50%
3 Extending beyond junction with
cross-sectional diameter of >50%
4 Totally occlusive deep venous
thrombosis
526 P. Marsh et al.saphenous surgery, with no increased risk of calf-DVT for
RFA with TRLOP in its absence. Any treatment of IPV with
concomitant small saphenous surgery was associated with
elevated risk of DVT. Whether this is a result of the small
saphenous surgical procedure itself or due to the increased
age and more severe disease of these patients is unknown.
The number of IPVs present has been correlated with clin-
ical severity and development of new IPV with worsening of
chronic venous disease.21,22 Varicose vein patients with
more advanced disease appear to have a higher risk of DVT.
All patients with DVT or EHIT in this series received
a single dose of prophylactic LMW heparin. Failure of this
strategy for prophylaxis has been reported previously,
especially in patients with a history of VTE.1,23 This suggests
that a greater duration of prophylaxis may be appropriate
in patients with a history of VTE, as has been suggested
previously.24 Pre-operative anticoagulation might interfere
with thrombotic vessel occlusion.25 A low DVT rate in
a large series (0.1%) was attributed to post-operative
treatment with non-steroidal anti-inflammatory drugs for
their anti-platelet activity and analgesic effect.17 Class II
graduated compression stockings may also be useful.
EHIT management has evolved in published reports from
operative thrombectomy, and later anticoagulation was
introducedwith orwithout saphenofemoral ligation.3,26 Caval
filters and thrombolysis have also been used, though most
authors now agree that treatment with low molecular weight
heparin is adequate formost cases.14,15,27 In this series, of the
patients with EHIT post-EVLA, 2 were anticoagulated and one
was observed. The latter patient had a knuckle of thrombus
protruding 1 cm into the femoral vein that was later seen to
have resolvedwith no adverse sequelae. Notwithstanding, wewould agree that such patients are probably most safely
managed with LMW heparin until resolution on ultrasound in
accordance with the suggested treatment algorithm Kabnick
introduced with his classification system (Table 7).5 All cases
of EHIT in this series were Kabnick class 2e4.
The risk of pulmonary embolism from EHIT remains
undefined and is uncommon after open varicose vein
surgery.28 We are unaware of any reports of patients with PE
directly in association with isolated EHIT, although there is
a report where it is not clear if calf-DVT has been excluded.27
The patient in this study with PE had thrombus present in
gastrocnemius veins as well as at the SFJ, similar to a previ-
ously described case.3 Routine post-operative DUS should be
performed specifically to seek the presence of EHIT in
accordance with consensus guidelines and therapeutic
management instigated and continued until absence of CFV
thrombus.5,29
DVT and EHIT after Endovenous Thermoablation 527The DVT rate including EHIT was similar in patients
treated with RFA and EVLA and was low. Calf-DVT occurred
in patients with a history of thromboembolism and in those
being treated for more complex venous disease. DVT rates
for both endothermal ablation techniques compare
favourably with those published for saphenous vein
stripping.Funding
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